Pelago
The partnership gives Lantern clients entry into customized substance use disorder treatment and telemedicine services.
The company offers a clinical vetting process and care-management pathway for individuals suffering from substance use disorders.
The recent investment brings the company's total raise to $151 million and will help it scale its offerings and conduct clinical research.